Company Profile

BioQuant (AKA: Michigan Research Corporation)
Profile last edited on: 4/25/18      CAGE:       UEI:

Business Identifier: Screening, diagnostic, monitoring tests in oncology, inflammation, immunology, & metabolic diseases
Year Founded
----
First Award
1985
Latest Award
1996
Program Status
Inactive (Acquired)
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

1370 Reynolds Avenue Suite 119
Irvine, CA 92614
   (714) 263-9933
   N/A
   N/A
Location: Single
Congr. District: 45
County: Orange

Public Profile

Bioquant was originally doing business as the Michigan Research Corporation with the firm's operations anchored in tehnology developed at University of Michigan. The firm subsequently relocated to Southern California and was renamed. in June 1996, BioQuant was acquired by Pacific Biometrics Inc., a publicly traded firm itself also being SBIR funded and in the business of developing diagnostics and offering laboratory services to detect and manage chronic diseases

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
1-4

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
1996 1 NIH $98,754
Project Title: New Monitor of Saliva Glucose for Diabetics
1995 1 NIH $91,576
Project Title: New Immodiagnostic Product for Saliva Proteins
1992 2 NIH $550,000
Project Title: Drugs of abuse in saliva
1992 1 NIH $49,993
Project Title: Lead in saliva
1991 2 NIH $529,478
Project Title: Immunosensor for drug monitoring

Key People / Management

  Bassam B Damaj -- CEO & CSO; Henry Esber, SVP, CBO, & Chairman

  Henry Esber -- Senior VP, Chief Business Officer

  Craig R Halberstadt

  Willfried Schramm

Company News

There are no news available.